You can find the annual or quarterly income statement of Amylyx Pharmaceuticals Inc here for insights into the performance and operational efficiency of Amylyx Pharmaceuticals Inc.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q2

FY2021Q1

FY2020Q4

Total revenue

-100.00%0.00

100.00%0.00

-100.00%0.00

-100.61%-665.00K

-99.59%416.00K

-101.04%-1.02M

24.10%88.64M

395.54%108.45M

29666.09%102.69M

--98.22M

--71.43M

--21.89M

--345.00K

----

-100.00%0.00

----

--350.00K

Revenue

-100.00%0.00

100.00%0.00

-100.00%0.00

-100.61%-665.00K

-99.59%416.00K

-101.04%-1.02M

24.10%88.64M

395.54%108.45M

29666.09%102.69M

--98.22M

--71.43M

--21.89M

--345.00K

----

-100.00%0.00

----

--350.00K

Cost of revenue

-100.00%0.00

-84.50%809.00K

32.94%7.42M

352.51%23.91M

231.80%9.36M

2933.72%5.22M

--5.58M

--5.28M

--2.82M

--172.00K

----

Operating expenses

-9.65%36.03M

-18.23%42.86M

-68.04%37.80M

-61.83%40.65M

-52.52%39.87M

-32.82%52.41M

60.96%118.27M

60.23%106.52M

52.61%83.97M

43.80%78.02M

53.68%73.48M

134.78%66.48M

--55.03M

191.89%54.25M

271.57%47.81M

216.65%28.32M

--18.59M

--12.87M

--8.94M

R&D expenses

-6.51%19.86M

16.58%27.22M

-39.58%22.12M

-49.03%22.89M

-29.30%21.24M

-19.62%23.35M

51.32%36.61M

96.88%44.91M

20.56%30.04M

19.72%29.04M

12.71%24.19M

70.32%22.81M

--24.91M

121.97%24.26M

212.70%21.46M

167.19%13.39M

--10.93M

--6.86M

--5.01M

Depreciation, depletion, and amortization

-45.70%120.00K

-32.21%141.00K

-50.48%156.00K

-46.84%160.00K

-26.82%221.00K

-25.98%208.00K

54.41%315.00K

65.38%301.00K

83.03%302.00K

167.62%281.00K

482.86%204.00K

727.27%182.00K

--165.00K

950.00%105.00K

250.00%35.00K

2100.00%22.00K

--10.00K

--1.00K

Other operating expenses

----

--665.00K

----

Operating profit

8.70%-36.03M

19.80%-42.86M

-27.58%-37.80M

-2202.07%-40.65M

-310.78%-39.46M

-364.52%-53.44M

-1343.25%-29.63M

104.34%1.93M

134.23%18.72M

137.23%20.20M

95.71%-2.05M

-57.49%-44.59M

---54.68M

-191.89%-54.25M

-271.57%-47.81M

-229.55%-28.32M

---18.59M

---12.87M

---8.59M

Net non-operating interest income (expenses)

Non-operating interest income

-41.22%1.82M

-51.83%1.96M

-48.43%2.23M

-47.01%2.32M

-25.87%3.10M

4.68%4.07M

16.35%4.33M

38.45%4.37M

595.34%4.18M

866.92%3.89M

2738.17%3.72M

10423.33%3.16M

--601.00K

40100.00%402.00K

6450.00%131.00K

--30.00K

--1.00K

--2.00K

--0.00

Non-operating interest expense

----

-100.00%0.00

----

--1.00K

Special income (expenses)

100.00%0.00

----

--0.00

---36.20M

---22.85M

---92.50M

--0.00

----

--0.00

100.00%0.00

--0.00

---3.31M

---1.92M

--0.00

Other non-operating income (expenses)

-27.66%-180.00K

-13.04%-546.00K

55.15%-335.00K

-8.19%157.00K

71.11%-141.00K

-496.30%-483.00K

-185.11%-747.00K

124.82%171.00K

-345.23%-488.00K

-92.86%-81.00K

-1278.95%-262.00K

-1067.80%-689.00K

--199.00K

-61.54%-42.00K

-107.28%-19.00K

-6000.00%-59.00K

---26.00K

--261.00K

--1.00K

Income before tax

52.70%-34.39M

42.99%-41.44M

69.71%-35.91M

-689.58%-38.18M

-424.41%-72.70M

-402.83%-72.70M

-8549.82%-118.55M

115.37%6.48M

141.59%22.41M

144.55%24.01M

102.94%1.40M

-48.62%-42.13M

---53.88M

-145.84%-53.89M

-228.46%-47.70M

-229.89%-28.34M

---21.92M

---14.52M

---8.59M

Income tax

--0.00

-100.00%0.00

-136.39%-635.00K

----

-100.00%0.00

242.35%242.00K

201.38%1.75M

1314.40%1.52M

1010.92%1.93M

-216.44%-170.00K

--579.00K

---125.00K

--174.00K

--146.00K

----

--0.00

----

Income after tax

52.70%-34.39M

42.99%-41.44M

69.77%-35.91M

-893.62%-37.55M

-447.98%-72.70M

-429.35%-72.70M

-7652.00%-118.79M

111.08%4.73M

138.87%20.89M

140.83%22.07M

103.29%1.57M

-50.66%-42.70M

---53.76M

-146.63%-54.07M

-229.46%-47.85M

-229.89%-28.34M

---21.92M

---14.52M

---8.59M

Net income from continuous operations

52.70%-34.39M

42.99%-41.44M

69.77%-35.91M

-893.62%-37.55M

-447.98%-72.70M

-429.35%-72.70M

-7652.00%-118.79M

111.08%4.73M

138.87%20.89M

140.83%22.07M

103.29%1.57M

-50.66%-42.70M

---53.76M

-146.63%-54.07M

-229.46%-47.85M

-229.89%-28.34M

---21.92M

---14.52M

---8.59M

Net income attributable to controlling interests

52.70%-34.39M

42.99%-41.44M

69.77%-35.91M

-893.62%-37.55M

-447.98%-72.70M

-429.35%-72.70M

-7652.00%-118.79M

111.08%4.73M

138.87%20.89M

140.83%22.07M

103.29%1.57M

-50.66%-42.70M

---53.76M

-146.63%-54.07M

-229.46%-47.85M

-229.89%-28.34M

---21.92M

---14.52M

---8.59M

Net income attributable to common shareholders

52.70%-34.39M

42.99%-41.44M

69.77%-35.91M

-893.62%-37.55M

-447.98%-72.70M

-429.35%-72.70M

-7652.00%-118.79M

111.08%4.73M

138.87%20.89M

140.83%22.07M

103.29%1.57M

-50.66%-42.70M

---53.76M

-146.63%-54.07M

-229.46%-47.85M

-229.89%-28.34M

---21.92M

---14.52M

---8.59M

Basic earnings per share

65.50%-0.37

56.50%-0.46

76.07%-0.42

-881.69%-0.55

-444.52%-1.07

-425.51%-1.07

-7524.55%-1.75

110.74%0.07

133.75%0.31

135.39%0.33

102.54%0.02

-29.90%-0.65

---0.92

-138.98%-0.93

-260.50%-0.93

-229.90%-0.50

---0.39

---0.26

---0.15

Diluted earnings per share

65.50%-0.37

56.50%-0.46

76.07%-0.42

-904.44%-0.55

-456.45%-1.07

-439.55%-1.07

-7986.08%-1.75

110.43%0.07

132.62%0.30

133.93%0.31

102.39%0.02

-29.90%-0.65

---0.92

-138.98%-0.93

-260.50%-0.93

-229.90%-0.50

---0.39

---0.26

---0.15

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

